Catalyst Wire Dossier Catalyst Wire Dossier

Aclarubicin

aclarubicin
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Aclarubicin, covering 2016-02-25 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL [Phase 3]

See pricing